Emerging Comorbidities in Adult Asthma: Risks, Clinical Associations, and Mechanisms

Mediators of Inflammation

Volumn 2016, Issue , 2016, Pages

  Kankaanranta, Hannu ^a,b   Kauppi, Paula ^c   Tuomisto, Leena E ^a   Ilmarinen, Pinja ^a  

^a SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; APOLIPOPROTEIN A1; C REACTIVE PROTEIN; DIMER; FIBRINOGEN; GELATINASE A; GELATINASE B; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INFLAMMASOME; INSULIN; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; LEUKOTRIENE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NOD LIKE RECEPTOR PROTEIN 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AIR POLLUTION; AIRWAY OBSTRUCTION; ALLERGIC RHINITIS; ANXIETY DISORDER; ASTHMA; BIPOLAR DISORDER; BRAIN ISCHEMIA; BRONCHIOLITIS; BRONCHITIS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EARLY LIFE STRESS; EOSINOPHIL; GENERALIZED ANXIETY DISORDER; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LUNG MECHANICS; MAJOR DEPRESSION; MATERNAL EXPOSURE; MATERNAL NUTRITION; MATERNAL SMOKING; MENTAL DISEASE; METABOLIC SYNDROME X; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OSTEOARTHRITIS; PANIC; PHOBIA; PNEUMONIA; POSTTRAUMATIC STRESS DISORDER; PREGNANCY COMPLICATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK FACTOR; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SUICIDE; TH17 CELL; TH2 CELL; UPPER RESPIRATORY TRACT INFECTION; WEIGHT REDUCTION; WORK DISABILITY; ANIMAL; COMPLICATION; METABOLISM;

ANIMALS; ASTHMA; DEPRESSION; DIABETES MELLITUS, TYPE 2; HUMANS; METABOLIC SYNDROME X; OBESITY; RISK FACTORS;

EID: 84971624311     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2016/3690628     Document Type: Review

References (220)

1. T. To, S. Stanojevic, G. Moores et al., "Global asthma prevalence in adults: findings fromthe cross-sectionalworld health survey," BMC Public Health, vol. 12, article 204, 2012.
2. S. B. de Nijs, L. N. Venekamp, and E. H. Bel, "Adult-onset asthma: is it really different?" European Respiratory Review, vol. 22, no. 127, pp. 44-52, 2013.
3. S. E. Wenzel, "Asthma phenotypes: the evolution fromclinical to molecular approaches," Nature Medicine, vol. 18, no. 5, pp. 716-725, 2012.
4. P. Ilmarinen, L. E. Tuomisto, and H. Kankaanranta, "Phenotypes, risk factors, and mechanisms of adult-onset asthma," Mediators of Inflammation, vol. 2015, Article ID 514868, 19 pages, 2015.
5. H. Bisgaard and K. Bonnelykke, "Long-term studies of the natural history of asthma in childhood," Journal of Allergy and Clinical Immunology, vol. 126, no. 2, pp. 187-197, 2010.
6. E. Rönmark, A. Lindberg, L. Watson, and B. Lundbäck, "Outcome and severity of adult onset asthma-report from the obstructive lung disease in northern Sweden studies (OLIN)," Respiratory Medicine, vol. 101, no. 11, pp. 2370-2377, 2007.
7. L. E. Tuomisto, P. Ilmarinen, and H. Kankaanranta, "Prognosis of new-onset asthma diagnosed at adult age," Respiratory Medicine, vol. 109, no. 8, pp. 944-954, 2015.
8. A. Sood, C. Qualls, M. Schuyler et al., "Adult-onset asthma becomes the dominant phenotype among women by age 40 years: the longitudinal CARDIA study," Annals of the American Thoracic Society, vol. 10, no. 3, pp. 188-197, 2013.
9. C. C. Imes and L. E. Burke, "The obesity epidemic: the United States as a cautionary tale for the rest of the world," Current Epidemiology Reports, vol. 1, no. 2, pp. 82-88, 2014.
10. K. Barnett, S. W. Mercer, M. Norbury, G. Watt, S. Wyke, and B. Guthrie, "Epidemiology ofmultimorbidity and implications for health care, research, and medical education: A cross-sectional study," The Lancet, vol. 380, no. 9836, pp. 37-43, 2012.
11. B. Pache, P. Vollenweider, G. Waeber, and P. Marques-Vidal, "Prevalence of measured and reported multimorbidity in a representative sample of the Swiss population," BMC Public Health, vol. 15, article 164, 2015.
12. S. W. Mercer, "Comorbidity in asthma is important and requires a generalist approach," PrimaryCare Respiratory Journal, vol. 23, no. 1, pp. 4-5, 2014.
13. J. M. Spergel, "From atopic dermatitis to asthma: the atopic march," Annals of Allergy, Asthma and Immunology, vol. 105, no. 2, pp. 99-106, 2010.
14. J. Bousquet, J. M. Anto, P. Demoly et al., "Severe chronic allergic (and related) diseases: A uniform approach-a MeDALL- GA2LEN-ARIA position paper," International Archives of Allergy and Immunology, vol. 158, no. 3, pp. 216-231, 2012.
15. C. A. Akdis, C. Bachert, C. Cingi et al., "Endotypes and phenotypes of chronic rhinosinusitis: A PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology," Journal of Allergy and Clinical Immunology, vol. 131, no. 6, pp. 1479-1490, 2013.
16. L. F. Eichenfield,W. L. Tom, S. L. Chamlin et al., "Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis," Journal of the American Academy of Dermatology, vol. 70, no. 2, pp. 338-351, 2014.
17. D. P. Guh, W. Zhang, N. Bansback, Z. Amarsi, C. L. Birmingham, and A. H. Anis, "The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis," BMC Public Health, vol. 9, article 88, 2009.
18. L.-P. Boulet and M.-E. Boulay, "Asthma-related comorbidities," Expert Review of RespiratoryMedicine, vol. 5, no. 3, pp. 377-393, 2011.
19. D. K. Ledford and R. F. Lockey, "Asthma and comorbidities," Current Opinion in Allergy and Clinical Immunology, vol. 13, no. 1, pp. 78-86, 2013.
20. M. Cazzola,A. Segreti, L. Calzetta, and P. Rogliani, "Comorbidities of asthma: current knowledge and future research needs," Current Opinion in Pulmonary Medicine, vol. 19, no. 1, pp. 36-41, 2013.
21. P. Kauppi, H. Kupiainen, A. Lindqvist et al., "Overlap syndrome of asthma and COPD predicts low quality of life," Journal of Asthma, vol. 48, no. 3, pp. 279-285, 2011.
22. Global Initiative for Asthma, Global Strategy for Asthma Management and Prevention, 2014, http://www. ginasthma. org.
23. Global Strategy for the Diagnosis,Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2014, http://www. goldcopd. org/.
24. M. Miravitlles, J. J. Soler-Cataluña, M. Calle et al., "Guía Española de la EPOC (GesEPOC). Tratamiento farmacológico de la EPOC estable," Archivos de Bronconeumología, vol. 48, no. 7, pp. 247-257, 2012.
25. H. Kankaanranta, T. Harju,M. Kilpeläinen et al., "Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines," Basic & Clinical Pharmacology and Toxicology, vol. 116, no. 4, pp. 291-307, 2015.
26. M. Miravitlles, J. J. Soler-Cataluña, M. Calle et al., "A new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD guidelines (GesEPOC)," Primary Care Respiratory Journal, vol. 22, no. 1, pp. 117-121, 2013.
27. Ø. Karlstad, P. Nafstad, A. Tverdal, S. Skurtveit, and K. Furu, "Comorbidities in an asthma population 8-29 years old: A study from theNorwegian PrescriptionDatabase," Pharmacoepidemiology and Drug Safety, vol. 21, no. 10, pp. 1045-1052, 2012.
28. A. S. Gershon, C. Wang, J. Guan, and T. To, "Burden of comorbidity in individuals with asthma," Thorax, vol. 65, no. 7, pp. 612-618, 2010.
29. A. S. Gershon, J. Guan, C. Wang, J. C. Victor, and T. To, "Describing and quantifying asthma comorbidty: A population study," PLoS ONE, vol. 7, no. 5,Article ID e34967, 2012.
30. J. B. Soriano, G. T. Visick,H. Muellerova,N. Payvandi, and A. L. Hansell, "Patterns of comorbidities in newly diagnosed COPD and asthma in primary care," Chest, vol. 128, no. 4, pp. 2099-2107, 2005.
31. H. Kankaanranta, A. Lahdensuo, E. Moilanen, and P. J. Barnes, "Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: A comprehensive review," Respiratory Research, vol. 5, article 17, 2004.
32. S. Suissa, A. Kezouh, and P. Ernst, "Inhaled corticosteroids and risks of diabetes onset and progression," American Journal of Medicine, vol. 123, no. 11, pp. 1001-1006, 2010.
33. K. Mattishent, M. Thavarajah, P. Blanco, D. Gilbert, A. M. Wilson, and Y. K. Loke, "Meta-review: Adverse effects of inhaled corticosteroids relevant to older patients," Drugs, vol. 74, no. 5, pp. 539-547, 2014.
34. H. Steppuhn, U. Langen, T. Keil, and C. Scheidt-Nave, "Chronic disease co-morbidity of asthma and unscheduled asthma care among adults: results of the national telephone health interview survey German health update (GEDA) 2009 and 2010," Primary Care Respiratory Journal, vol. 23, no. 1, pp. 22-29, 2014.
35. R. Hakola, P. Kauppi, T. Leino et al., "Persistent asthma, comorbid conditions and the risk of work disability: A prospective cohort study," Allergy, vol. 66, no. 12, pp. 1598-1603, 2011.
36. D. Gibeon, K. Batuwita, M. Osmond et al., "Obesity-associated severe asthma represents a distinct clinical phenotype. Analysis of the british thoracic society difficult asthma registry patient cohort according to BMI," Chest, vol. 143, no. 2, pp. 406-414, 2013.
37. Z. Ali and C. S. Ulrik, "Obesity and asthma: A coincidence or a causal relationship? A systematic review," RespiratoryMedicine, vol. 107, no. 9, pp. 1287-1300, 2013.
38. P. Sivapalan, Z. Diamant, and C. S. Ulrik, "Obesity and asthma: current knowledge and future needs," Current Opinion in Pulmonary Medicine, vol. 21, no. 1, pp. 80-85, 2014.
39. L. Wang, K. Wang, X. Gao, T. K. Paul, J. Cai, and Y. Wang, "Sex difference in the association between obesity and asthma inU. S. adults: findings from a national study," Respiratory Medicine, vol. 109, no. 8, pp. 955-962, 2015.
40. B. Brumpton,A. Langhammer, P. Romundstad, Y. Chen, and X.-M. Mai, "General and abdominal obesity and incident asthmain adults: the HUNT study," European Respiratory Journal, vol. 41, no. 2, pp. 323-329, 2013.
41. N. Assad, C. Qualls, L. J. Smith et al., "Body mass index is a stronger predictor than the metabolic syndrome for future asthma in women. The longitudinal CARDIA study," American Journal of Respiratory and Critical CareMedicine, vol. 188, no. 3, pp. 319-326, 2013.
42. M. Ruotsalainen, V. Sidoroff, E. Piippo-Savolainen, M. K. Hyvärinen, and M. Korppi, "Association between overweight and asthma or allergy: results from a prospective 27-year postbronchiolitis follow-up," Current Pediatric Research, vol. 16, no. 2, pp. 95-100, 2012.
43. J. I. Peters, J. M. McKinney, B. Smith, P. Wood, E. Forkner, and A. D. Galbreath, "Impact of obesity in asthma: evidence from a large prospective disease management study," Annals of Allergy, Asthma and Immunology, vol. 106, no. 1, pp. 30-35, 2011.
44. S. Pakhale, S. Doucette, K. Vandemheen et al., "A comparison of obese and nonobese people with asthma: exploring an asthmaobesity interaction," Chest, vol. 137, no. 6, pp. 1316-1323, 2010.
45. S. Scott, J. Currie, P. Albert, P. Calverley, and J. P. H. Wilding, "Risk of misdiagnosis, health-related quality of life, and BMI in patients who are overweight with doctor-diagnosed asthma," Chest, vol. 141, no. 3, pp. 616-624, 2012.
46. A. Lessard, H. Turcotte, Y. Cormier, and L.-P. Boulet, "Obesity and asthma: A specific phenotype?" Chest, vol. 134, no. 2, pp. 317-323, 2008.
47. F. Holguin, E. R. Bleecker, W. W. Busse et al., "Obesity and asthma: An association modified by age of asthma onset," Journal of Allergy and Clinical Immunology, vol. 127, no. 6, pp. 1486. e2-1493. e2, 2011.
48. D. Gibeon, K. Batuwita, M. Osmond et al., "Obesity-associated severe asthma represents a distinct clinical phenotype analysis of the british thoracic society diffi cult asthma registry patient cohort according to BMI," Chest, vol. 143, no. 2, pp. 406-414, 2013.
49. A. Bruno, E. Pace, F. Cibella, and P. Chanez, "Bodymass index and comorbidities in adult severe asthmatics," BioMed Research International, vol. 2014, Article ID 607192, 7 pages, 2014.
50. A. K. Ramasamy, N. Gupta, and R. Kumar, "Impact of obesity on bronchial asthma in Indian population," Lung India, vol. 31, no. 2, pp. 121-126, 2014.
51. G. Ciprandi, I. Schiavetti, R. B. Fontana, V. Sorbello, and F. L. M. Ricciardolo, "Overweight and obesity as risk factors for impaired lung function in patients with asthma: A real-life experience," Allergy and Asthma Proceedings, vol. 35, no. 4, pp. e62-e71, 2014.
52. B. Taylor, D. Mannino, C. Brown, D. Crocker, N. Twum-Baah, and F. Holguin, "Body mass index and asthma severity in the National Asthma Survey," Thorax, vol. 63, no. 1, pp. 14-20, 2008.
53. J. E. Cotes, D. J. Chinn, and J. W. Reed, "Body mass, fat percentage, and fat free mass as reference variables for lung function: effects on terms for age and sex," Thorax, vol. 56, no. 11, pp. 839-844, 2001.
54. M. S. Biring, M. I. Lewis, J. T. Liu, and Z. Mohsenifar, "Pulmonary physiologic changes of morbid obesity," The American Journal of theMedical Sciences, vol. 318, no. 5, pp. 293-297, 1999.
55. G. N. Bedell, W. R. Wilson, and P. M. Seebohm, "Pulmonary function in obese persons," Journal of Clinical Investigation, vol. 37, no. 7, pp. 1049-1060, 1958.
56. M. Schatz, R. S. Zeiger, S. J. Yang et al., "Prospective study on the relationship of obesity to asthma impairment and risk," The Journal of Allergy and Clinical Immunology: In Practice, vol. 3, no. 4, pp. 560. e1-565. e1, 2015.
57. B. Stenius-Aarniala, T. Poussa, J. Kvarnström, E.-L. Grönlund, M. Ylikahri, and P. Mustajoki, "Immediate and long termeffects of weight reduction in obese people with asthma: randomised controlled study," BritishMedical Journal, vol. 320, no. 7238, pp. 827-832, 2000.
58. H. A. Scott, P. G. Gibson, M. L. Garg et al., "Dietary restriction and exercise improve airway inflammation and clinical outcomes in overweight and obese asthma: A randomized trial," Clinical and Experimental Allergy, vol. 43, no. 1, pp. 36-49, 2013.
59. S. Pakhale, J. Baron, R. Dent, K. Vandemheen, and S. D. Aaron, "Effects of weight loss on airway responsiveness in obese adults with asthma. Does weight loss lead to reversibility of asthma?" Chest, vol. 147, no. 6, pp. 1582-1590, 2015.
60. L.-P. Boulet, H. Turcotte, J. Martin, and P. Poirier, "Effect of bariatric surgery on airway response and lung function in obese subjects with asthma," Respiratory Medicine, vol. 106, no. 5, pp. 651-660, 2012.
61. A. van Huisstede, A. Rudolphus, M. Castro Cabezas et al., "Effect of bariatric surgery on asthma control, lung function and bronchial and systemic inflammation in morbidly obese subjects with asthma," Thorax, vol. 70, no. 7, pp. 659-667, 2015.
62. A. E. Dixon, R. E. Pratley, P. M. Forgione et al., "Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control and inflammation," Journal of Allergy and Clinical Immunology, vol. 128, no. 3, pp. 508-515, 2011.
63. K. Hasegawa, Y. Tsugawa, Y. Chang, and C. A. Camargo, "Riskof an asthmaexacerbation after bariatric surgery in adults," Journal of Allergy and Clinical Immunology, vol. 136, no. 2, pp. 288-294, 2015.
64. J. V. Garmendia, D. Moreno, A. H. García, and J. B. De Sanctis, "Metabolic syndrome and asthma," Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, vol. 8, no. 1, pp. 60-66, 2014.
65. B. M. Brumpton, C. A. Camargo Jr., P. R. Romundstad, A. Langhammer, Y. Chen, and X.-M. Mai, "Metabolic syndrome and incidence of asthma in adults: the HUNT study," European Respiratory Journal, vol. 42, no. 6, pp. 1495-1502, 2013.
66. E. J. Lee, K. H. In, E. S. Ha et al., "Asthma-like symptoms are increased in the metabolic syndrome," Journal of Asthma, vol. 46, no. 4, pp. 339-342, 2009.
67. M. B. Fessler, "Next stop for HDL: the lung," Clinical and Experimental Allergy, vol. 42, no. 3, pp. 340-342, 2013.
68. M. B. Fessler, "Revisiting 'Good' and 'Bad' cholesterol. Thebattle over flow through arteries now shifts to flow through airways," American Journal of Respiratory and Critical CareMedicine, vol. 191, no. 9, pp. 969-970, 2015.
69. P. L. Enright, B. J. Ward, R. P. Tracy, and E. C. Lasser, "Asthma and its association with cardiovascular disease in the elderly. The carciovascular health study research group," Journal of Asthma, vol. 33, no. 1, pp. 45-53, 1996.
70. C. Picado, R. Deulofeu, R. Lleonart et al., "Lipid and protein metabolism in asthma. Effects of diet and corticosteroid therapy," Allergy, vol. 54, no. 6, pp. 569-575, 1999.
71. A. V. Barochia,M. Kaler, R. A. Cuentoet al., "Serumapolipoprotein A-I and large high-density lipoprotein particles are positively correlated with FEV1 in atopic asthma," American Journal of Respiratory and Critical CareMedicine, vol. 191, no. 9,pp. 990-1000, 2015.
72. S. Dogra, C. I. Ardern, and J. Baker, "The relationship between age of asthma onset and cardiovascular disease in Canadians," Journal of Asthma, vol. 44, no. 10, pp. 849-854, 2007.
73. T. Zhang, B. C. Carleton, R. J. Prosser, and A. M. Smith, "The added burden of comorbidity in patients with asthma," Journal of Asthma, vol. 46, no. 10, pp. 1021-1026, 2009.
74. D. A. Hickson, R. L. Wilhite, M. F. Petrini,W. B. White, and C. Burchfiel, "Asthma and asthma severity among african american adults in the Jackson Heart Study," Journal of Asthma, vol. 46, no. 4, pp. 421-428, 2009.
75. M. Johnson, J. Nriagu, A. Hammad, K. Savoie, and H. Jamil, "Asthma, environmental risk factors, and hypertension among Arab Americans in metro Detroit," Journal of Immigrant and Minority Health, vol. 12, no. 5, pp. 640-651, 2010.
76. S. C. Christiansen,M. Schatz, S.-J. Yang, E. Ngor,W. Chen, and B. L. Zuraw, "Hypertension and asthma: A comorbid relationship," Journal of AllergyandClinical Immunology inPractice, vol. 2, pp. S2213-2198, 2015, [Epub ahead of print].
77. N. Nurminen, S. Oikarinen, and H. Hyöty, "Virus infections as potential targets of preventive treatments for type 1 diabetes," The Review of Diabetic Studies, vol. 9, no. 4, pp. 260-271, 2012.
78. S. F. Ehrlich, C. P. Quesenberry Jr., S. K. Van Den Eeden, J. Shan, and A. Ferrara, "Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer," Diabetes Care, vol. 33, no. 1, pp. 55-60, 2010.
79. S. F. Thomsen, D. L. Duffy, K. O. Kyvik, A. Skytthe, and V. Backer, "Risk of asthma in adult twins with type 2 diabetes and increased bodymass index," Allergy, vol. 66, no. 4, pp. 562-568, 2011.
80. M. Hashemzadeh and M. R. Movahed, "The occurrence of asthma in hospitalized patients with type 2 diabetes mellitus," Internal Medicine Journal, vol. 39, no. 10, pp. 699-701, 2009.
81. N. T. Mueller, W.-P. Koh, A. O. Odegaard, M. D. Gross, J.-M. Yuan, and M. A. Pereira, "Asthma and the risk of type 2 diabetes in the Singapore Chinese Health Study," Diabetes Research and Clinical Practice, vol. 99, no. 2, pp. 192-199, 2013.
82. P. M. O'Byrne, S. Rennard, H. Gerstein et al., "Risk of new onset diabetesmellitus in patients with asthma or COPDtaking inhaled corticosteroids," Respiratory Medicine, vol. 106, no. 11, pp. 1487-1493, 2012.
83. J. S. Rana,M. A. Mittleman, J. Sheikhet al., "Chronicobstructive pulmonary disease, asthma, and risk of type 2 diabetes in women," Diabetes Care, vol. 27, no. 10, pp. 2478-2484, 2004.
84. Y. Song, A. Klevak, J. E. Manson, J. E. Buring, and S. Liu, "Asthma, chronic obstructive pulmonary disease, and type 2 diabetes in the Women's Health Study," Diabetes Research and Clinical Practice, vol. 90, no. 3, pp. 365-371, 2010.
85. H. D. Yun, E. Knoebel, Y. Fenta et al., "Asthma and proinflammatory conditions: A population-based retrospective matched cohort study," Mayo Clinic Proceedings, vol. 87, no. 10, pp. 953-960, 2012.
86. K. Torén and N. B. Lindholm, "Do patients with severe asthma run an increased risk from ischaemic heart disease?" International Journal of Epidemiology, vol. 25, no. 3, pp. 617-620, 1996.
87. V. Bellia, C. Pedone, F. Catalano et al., "Asthma in the elderly: mortality rate and associated risk factors for mortality," Chest, vol. 132, no. 4, pp. 1175-1182, 2007.
88. H. M. Lee, S. T. Truong, and N. D. Wong, "Association of adult-onset asthma with specific cardiovascular conditions," Respiratory Medicine, vol. 106, no. 7, pp. 948-953, 2012.
89. C. Iribarren, I. V. Tolstykh, and M. D. Eisner, "Are patients with asthma at increased risk of coronary heart disease?" International Journal of Epidemiology, vol. 33, no. 4, pp. 743-748, 2004.
90. M. Szklo, R. Barnes, A. Folsom et al., "The atherosclerosis risk in communities (ARIC) study: design and objectives,"American Journal of Epidemiology, vol. 129, no. 4, pp. 687-702, 1989.
91. J. G. Schanen, C. Iribarren, E. Shahar et al., "Asthma and incident cardiovascular disease: the Atherosclerosis Risk in Communities study," Thorax, vol. 60, no. 8, pp. 633-638, 2005.
92. S. Onufrak, J. Abramson, and V. Vaccarino, "Adult-onset asthma is associated with increased carotid atherosclerosis among women in the atherosclerosis risk in communities (ARIC) study," Atherosclerosis, vol. 195, no. 1, pp. 129-137, 2007.
93. S. J. Onufrak, J. L. Abramson, H. D. Austin, F. Holguin, W. M. McClellan, and L. V. Vaccarino, "Relation of adult-onset asthma to coronary heart disease and stroke," American Journal of Cardiology, vol. 101, no. 9, pp. 1247-1252, 2008.
94. C. Iribarren, I. V. Tolstykh, M. K. Miller, E. Sobel, and M. D. Eisner, "Adult asthma and risk of coronary heart disease, cerebrovascular disease, and heart failure: A prospective study of 2 matched cohorts," American Journal of Epidemiology, vol. 176, no. 11, pp. 1014-1024, 2012.
95. M. C. Tattersall, M. Guo, C. E. Korcarz et al., "Asthma predicts cardiovascular disease events: the multi-ethnic study of atherosclerosis," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 35, no. 6, pp. 1520-1525, 2015.
96. Y. Ç olak, S. Afzal, B. G. Nordestgaard, and P. Lange, "Characteristics and prognosis of never-smokers and smokers with asthma in the copenhagen general population study. A prospective cohort study," American Journal of Respiratory and Critical Care Medicine, vol. 192, no. 2, pp. 172-181, 2015.
97. M. Pujades-Rodriquez, J. George, A. D. Shah et al., "Heterogeneous associations between smoking and a wide range of initial presentations of cardiovascular disease in 1 937 360 people in England: lifetime risks and implications for risk prediction," International Journal of Epidemiology, vol. 44, no. 1, pp. 129-141, 2015.
98. J. Garcia-Aymerich, "The role of smoking in the association between asthma and cardiovascular disease. An example of poorly controlled confounding," American Journal of Respiratory and Critical Care Medicine, vol. 192, no. 2, p. 123, 2015.
99. M. Opolski and I. Wilson, "Asthma and depression: A pragmatic review of the literature and recommendations for future research," Clinical Practice and Epidemiology in Mental Health, vol. 1, article 18, 2005.
100. T. Ritz, A. E. Meuret, A. F. Trueba, A. Fritzsche, and A. von Leupoldt, "Psychosocial factors and behavioral medicine interventions in asthma," Journal of Consulting and Clinical Psychology, vol. 81, no. 2, pp. 231-250, 2013.
101. K. M. Scott, M. Von Korff, J. Ormel et al., "Mental disorders among adultswith asthma: results from the worldmental health Survey," General Hospital Psychiatry, vol. 29, no. 2, pp. 123-133, 2007.
102. E. B. Weiser, "The prevalence of anxiety disorders among adults with asthma: A meta-analytic review," Journal of Clinical Psychology in Medical Settings, vol. 14, no. 4, pp. 297-307, 2007.
103. M. Jiang, P. Qin, and X. Yang, "Comorbidity between depression and asthma via immune-inflammatory pathways: A metaanalysis," Journal of Affective Disorders, vol. 166, pp. 22-29, 2014.
104. J. De Miguel Diez, V. Hernandez-Barrera, L. P. Maestu, P. C. Garrido, T. Gomez Garcia, and R. Jimenez Garcia, "Psychiatric comorbidity in asthma patients. Associated factors," Journal of Asthma, vol. 48, no. 3, pp. 253-258, 2011.
105. R. D. Goodwin,F. Jacobi, and W. Thefeld, "Mentaldisorders and asthma in the community," Archives of General Psychiatry, vol. 60, no. 11, pp. 1125-1130, 2003.
106. C. Q. Jiang, A. Loerbroks, K.-B. H. Lam et al., "Mental health and asthma in China: the Guangzhou Biobank Cohort Study," International Journal of Behavioral Medicine, vol. 20, no. 2, pp. 259-264, 2013.
107. K. O. Wong, B. H. Rowe, J. Douwes, and A. Senthilselvan, "Asthma and wheezing are associated with depression and anxiety in adults: An analysis from 54 countries," Pulmonary Medicine, vol. 2013, Article ID 929028, 10 pages, 2013.
108. W. J. Katon, L. Richardson, P. Lozano, and E. McCauley, "The relationship of asthma and anxiety disorders," Psychosomatic Medicine, vol. 66, no. 3, pp. 349-355, 2004.
109. M. J. Slattery and M. J. Essex, "Specificity in the association of anxiety, depression, and atopic disorders in a community sample of adolescents," Journal of Psychiatric Research, vol. 45, no. 6, pp. 788-795, 2011.
110. I. Olssøn and A. A. Dahl, "Personality problems are considerably associated with somatic morbidity and health care utilisation," European Psychiatry, vol. 24, no. 7, pp. 442-449, 2009.
111. N. Iessa, M. L. Murray, S. Curran, and I. C. K. Wong, "Asthma and suicide-related adverse events: A review of observational studies," European Respiratory Review, vol. 20, no. 122, pp. 287-292, 2011.
112. M. S. Pedersen,M. E. Benros, E. Agerbo, A. D. Børglum, and P. B. Mortensen, "Schizophrenia in patients with atopic disorders with particular emphasis on asthma: A Danish populationbased study," Schizophrenia Research, vol. 138, no. 1, pp. 58-62, 2012.
113. K. M. Scott, M. V. Korff, J. Alonso et al., "Childhood adversity, early-onset depressive/anxiety disorders, and adult-onset asthma," Psychosomatic Medicine, vol. 70, no. 9, pp. 1035-1043, 2008.
114. J. Alonso, P. de Jonge, C. C. W. Limet al., "Association between mental disorders and subsequent adult onset asthma," Journal of Psychiatric Research, vol. 59, pp. 179-188, 2014.
115. N. Hutter, A. Knecht, and H. Baumeister, "Health care costs in persons with asthma and comorbid mental disorders. A systematic review," General Hospital Psychiatry, vol. 33, no. 5, pp. 443-453, 2011.
116. K. L. Lavoie, S. L. Bacon, S. Barone, A. Cartier, B. Ditto, and M. Labrecque, "What isworse for asthma control and qualityof life: depressive disorders, anxiety disorders, or both?" Chest, vol. 130, no. 4, pp. 1039-1047, 2006.
117. K. L. Lavoie,M. Boudreau, A. Plourde, T. S. Campbell, and S. L. Bacon, "Association between generalized anxiety disorder and asthma morbidity," Psychosomatic Medicine, vol. 73, no. 6, pp. 504-513, 2011.
118. H. Favreau, S. L. Bacon, M. Labrecque, and K. L. Lavoie, "Prospective impact of panic disorder and panic-anxiety on asthma control, health service use, and quality of life in adult patients with asthma over a 4-year follow-up," Psychosomatic Medicine, vol. 76, no. 2, pp. 147-155, 2014.
119. A. ten Brinke, M. E. Ouwerkerk, A. H. Zwinderman, P. Spinhoven, and E. H. Bel, "Psychopathology in patients with severe asthma is associated with increased health care utilization," American Journal of Respiratory and Critical CareMedicine, vol. 163, no. 5, pp. 1093-1096, 2001.
120. K. Ouellet, S. L. Bacon, M. Boudreau, A. Plourde, G. Moullec, and K. L. Lavoie, "Individual and combined impact of cigarette smoking, anxiety, and mood disorders on asthma control," Nicotine & Tobacco Research, vol. 14, no. 8, pp. 961-969, 2012.
121. M. Boudreau, S. L. Bacon, K. Ouellet, A. Jacob, and K. L. Lavoie, "Mediator effect of depressive symptoms on the association between BMI and asthma control in adults," Chest, vol. 146, no. 2, pp. 348-354, 2014.
122. S. G. Kapadia, C. Wei, S. J. Bartlett, J. Lang, R. A. Wise, and A. E. Dixon, "Obesity and symptoms of depression contribute independently to the poor asthma control of obesity," Respiratory Medicine, vol. 108, no. 8, pp. 1100-1107, 2014.
123. M. B. Stein, B. J. Cox, T. O. Afifi, S.-L. Belik, and J. Sareen, "Does co-morbid depressive illness magnify the impact of chronic physical illness? A population-based perspective," Psychological Medicine, vol. 36, no. 5, pp. 587-596, 2006.
124. A. van Huisstede, A. Rudolphus, A. van Schadewijk et al., "Bronchial and systemic inflammation in morbidly obese subjects with asthma: A biopsy study," American Journal of Respiratory and Critical Care Medicine, vol. 190, no. 8, pp. 951-954, 2014.
125. D. Desai, C. Newby, F. A. Symon et al., "Elevated sputum interleukin-5 and submucosal eosinophilia in obese individuals with severe asthma," American Journal of Respiratory and Critical Care Medicine, vol. 188, no. 6, pp. 657-663, 2013.
126. I. H. van Veen, A. Ten Brinke, P. J. Sterk, K. F. Rabe, and E. H. Bel, "Airway inflammation in obese and nonobese patients with difficult-to-treat asthma," Allergy, vol. 63, no. 5, pp. 570-574, 2008.
127. T. J. T. Sutherland, J. O. Cowan, S. Young et al., "The association between obesity and asthma: interactions between systemic and airway inflammation," American Journal of Respiratory and Critical Care Medicine, vol. 178, no. 5, pp. 469-475, 2008.
128. W. C. Moore, A. T. Hastie, X. Li et al., "Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis," The Journal of Allergy and Clinical Immunology, vol. 133, no. 6, pp. 1557-1563. e5, 2014.
129. J. R. O'Reilly and R. M. Reynolds, "The risk ofmaternal obesity to the long-term health of the offspring," Clinical Endocrinology, vol. 78, no. 1, pp. 9-16, 2013.
130. E. Forno,O. M. Young, R. Kumar, H. Simhan, and J. C. Celedón, "Maternal obesity in pregnancy, gestational weight gain, and risk of childhood asthma," Pediatrics, vol. 134, no. 2, pp. e535-e546, 2014.
131. R. C. Johnson and R. F. Schoeni, "Early-life origins of adult disease: national longitudinal population-based study of the United States," American Journal of Public Health, vol. 101, no. 12, pp. 2317-2324, 2011.
132. C. J. Smith and K. K. Ryckman, "Epigenetic and developmental influences on the risk of obesity, diabetes, and metabolic syndrome," Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, vol. 8, pp. 295-302, 2015.
133. P. D. Gluckman,M. A. Hanson,C. Cooper, and K. L. Thornburg, "Effect of in utero and early-life conditions on adult health and disease," The New England Journal of Medicine, vol. 359, no. 1, pp. 61-73, 2008.
134. A. Danese, T. E. Moffitt, C. M. Pariante, A. Ambler, R. Poulton, and A. Caspi, "Elevated inflammation levels in depressed adults with a history of childhood maltreatment," Archives of General Psychiatry, vol. 65, no. 4, pp. 409-416, 2008.
135. G. E. Miller and S. W. Cole, "Clustering of depression and inflammation in adolescents previously exposed to childhood adversity," Biological Psychiatry, vol. 72, no. 1, pp. 34-40, 2012.
136. P. F. Coogan, L. A. Wise, G. T. O'Connor, T. A. Brown, J. R. Palmer, and L. Rosenberg, "Abuse during childhood and adolescence and risk of adult-onset asthma in African American women," The Journal of Allergy and Clinical Immunology, vol. 131, no. 4, pp. 1058-1063, 2013.
137. R. J. Van Lieshout, J. Bienenstock, and G. M. MacQueen, "A review of candidate pathways underlying the association between asthma and major depressive disorder," Psychosomatic Medicine, vol. 71, no. 2, pp. 187-195, 2009.
138. L. G. Wood, K. J. Baines, J. Fu,H. A. Scott, and P. G. Gibson, "The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma," Chest, vol. 142, no. 1, pp. 86-93, 2012.
139. K. J. Baines, V. Backer, P. G. Gibson, H. Powel, and C. M. Porsbjerg, "Impaired lung function is associated with systemic inflammation and macrophage activation," The European Respiratory Journal, vol. 45, no. 2, pp. 557-559, 2015.
140. J. B. Morjaria, K. S. Babu, P. Vijayanand, A. J. Chauhan, D. E. Davies, and S. T. Holgate, "SputumIL-6 concentrations in severe asthma and its relationship with FEV1," Thorax, vol. 66, no. 6, p. 537, 2011.
141. H. Kankaanranta, P. Ilmarinen, X. Zhang et al., "Tumour necrosis factor- regulates human eosinophil apoptosis via ligation of TNF-receptor 1 and balance between NFB and AP-1," PLoS ONE, vol. 9, no. 2,Article ID e90298, 2014.
142. C. A. Hunter and S. A. Jones, "IL-6 as a keystone cytokine in health and disease," Nature Immunology, vol. 16, no. 5, pp. 448-457, 2015.
143. M. Rincon and C. G. Irvin, "Role of IL-6 in asthma and other inflammatory pulmonary diseases," International Journal of Biological Sciences, vol. 8, no. 9, pp. 1281-1290, 2012.
144. C. Irvin, I. Zafar, J. Good et al., "Increased frequency of dual-positive TH2/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma," The Journal of Allergy and Clinical Immunology, vol. 134, no. 5, pp. 1175. e7-1186. e7, 2014.
145. M. Jagannathan-Bogdan, M. E. McDonnell, H. Shin et al., "Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes," Journal of Immunology, vol. 186, no. 2, pp. 1162-1172, 2011.
146. E. Fabbrini, M. Cella, S. A. McCartney et al., "Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals," Gastroenterology, vol. 145, no. 2, pp. 366. e1-374. e3, 2013.
147. V. Schmitt, L. Rink, and P. Uciechowski, "TheTh17/Treg balance is disturbed during aging," Experimental Gerontology, vol. 48, no. 12, pp. 1379-1386, 2013.
148. C. Brandenberger, N. Li, D. N. Jackson-Humbles, C. E. Rockwell, J. G. Wagner, and J. R. Harkema, "Enhancedallergic airway disease in old mice is associated with a Th17 response," Clinical & Experimental Allergy, vol. 44, no. 10, pp. 1282-1292, 2014.
149. T. Wang, Y. Ji, Y. Yang et al., "Transcriptomic profiling of peripheral blood CD4+ T-cells in asthmatics with and without depression," Gene, vol. 565, no. 2, pp. 282-287, 2015.
150. O. J. G. Schiepers, M. C. Wichers, and M. Maes, "Cytokines and major depression," Progress in Neuro-Psychopharmacology & Biological Psychiatry, vol. 29, no. 2, pp. 201-217, 2005.
151. M. C. Wichers and M. Maes, "The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alphainduced depression," Journal of Psychiatry & Neuroscience, vol. 29, no. 1, pp. 11-17, 2004.
152. M. Haneklaus and L. A. O'Neill, "NLRP3 at the interface of metabolism and inflammation," Immunological Reviews, vol. 265, no. 1, pp. 53-62, 2015.
153. M. Iwata, K. T. Ota, and R. S. Duman, "The inflammasome: pathways linking psychological stress, depression, and systemic illnesses," Brain, Behavior, and Immunity, vol. 31, pp. 105-114, 2013.
154. S. R. Kim, D. I. Kim, S. H. Kim et al., "NLRP3 inflammasome activation by mitochondrial ROS in bronchial epithelial cells is required for allergic inflammation," Cell Death & Disease, vol. 5, no. 10, Article ID e1498, 2014.
155. C.-B. Zhu, K. M. Lindler, A. W. Owens, L. C. Daws, R. D. Blakely, and W. A. Hewlett, "Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked toMAPK regulation of CNS serotonin transporters," Neuropsychopharmacology, vol. 35, no. 13, pp. 2510-2520, 2010.
156. S. Ramamoorthy, J. D. Ramamoorthy, P. D. Prasad et al., "Regulation of the human serotonin transporter by interleukin-1," Biochemical and Biophysical Research Communications, vol. 216, no. 2, pp. 560-567, 1995.
157. H. Y. Kim, H. J. Lee,Y.-J. Chang et al., "Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity," Nature Medicine, vol. 20, no. 1, pp. 54-61, 2014.
158. T. J. T. Sutherland,M. R. Sears, C. R. McLachlan, R. Poulton, and R. J. Hancox, "Leptin, adiponectin, and asthma: findings from a population-based cohort study," Annals of Allergy, Asthma & Immunology, vol. 103, no. 2, pp. 101-107, 2009.
159. M. Canöz, F. Erdenen,H. Uzun, C. Müderrisoglu, and S. Aydin, "The relationship of inflammatory cytokines with asthma and obesity," Clinical and Investigative Medicine, vol. 31, no. 6, pp. E373-E379, 2008.
160. C. E. Ruhl and J. E. Everhart, "Leptin concentrations in the United States: relations with demographic and anthropometric measures," The American Journal of Clinical Nutrition, vol. 74, no. 3, pp. 295-301, 2001.
161. O. Sideleva, B. T. Suratt,K. E. Black et al., "Obesity and asthma: An inflammatory disease of adipose tissue not the airway," American Journal of Respiratory and Critical CareMedicine, vol. 186, no. 7, pp. 598-605, 2012.
162. S. A. Shore, I. N. Schwartzman, M. S. Mellema, L. Flynt, A. Imrich, and R. A. Johnston, "Effect of leptin on allergic airway responses in mice,"The Journal of Allergy and Clinical Immunology, vol. 115, no. 1, pp. 103-109, 2005.
163. J. H. J. Vernooy, N. D. J. Ubags, G. G. Brusselle et al., "Leptin as regulator of pulmonary immune responses: involvement in respiratory diseases," Pulmonary Pharmacology & Therapeutics, vol. 26, no. 4, pp. 464-472, 2013.
164. S. Leivo-Korpela, L. Lehtimäki, K. Vuolteenaho et al., "Adipokine resistin predicts anti-inflammatory effect of glucocorticoids in asthma," Journal of Inflammation, vol. 8, article 12, 2011.
165. A. Bruno, E. Pace, P. Chanez et al., "Leptin and leptin receptor expression in asthma," The Journal of Allergy and Clinical Immunology, vol. 124, no. 2, pp. 237. e1-237. e4, 2009.
166. J. H. Shin, J. H. Kim,W. Y. Lee, and J. Y. Shim, "The expression of adiponectin receptors and the effects of adiponectin and leptin on airway smooth muscle cells," Yonsei Medical Journal, vol. 49, no. 5, pp. 804-810, 2008.
167. P. Ilmarinen and H. Kankaanranta, "Eosinophil apoptosis as a therapeutic target in allergic asthma," Basic & Clinical Pharmacology & Toxicology, vol. 114, no. 1, pp. 109-117, 2014.
168. S. Conus, A. Bruno, and H.-U. Simon, "Leptin is an eosinophil survival factor,"The Journal of Allergy and Clinical Immunology, vol. 116, no. 6, pp. 1228-1234, 2005.
169. H. Lai, N. Lin, Z. Xing, H. Weng, and H. Zhang, "Association between the level of circulating adiponectin and prediabetes: A meta-analysis," Journal ofDiabetes Investigation, vol. 6, no. 4,pp. 416-429, 2015.
170. A. Sood, C. Qualls, M. Schuyler et al., "Low serum adiponectin predicts future risk for asthma in women," American Journal of Respiratory and Critical CareMedicine, vol. 186, no. 1, pp. 41-47, 2012.
171. A. Sood and S. A. Shore, "Adiponectin, leptin, and resistin in asthma: basic mechanisms through population studies," Journal of Allergy, vol. 2013, Article ID 785835, 15 pages, 2013.
172. S. K. Davis, S. Y. Gebreab, R. Xu et al., "Association of adiponectin with type 2 diabetes and hypertension in African American men and women: the Jackson Heart study," BMC Cardiovascular Disorders, vol. 15, article 13, 2015.
173. A. Sood, E. Dominic, and C. Qualls, "Serum adiponectin is associated with adverse outcomes of asthma in men but not in women," Frontiers in Pharmacology, vol. 2, article 55, 2011.
174. K. M. Ajuwon and M. E. Spurlock, "Adiponectin inhibits LPSinduced NFB activation and IL-6 production and increases PPAR 2 expression in adipocytes," The American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 288, no. 5, pp. R1220-R1225, 2005.
175. E. J. Folco, V. Z. Rocha, M. López-Ilasaca, and P. Libby, "Adiponectin inhibits pro-inflammatory signaling in human macrophages independent of interleukin-10," The Journal of Biological Chemistry, vol. 284, no. 38, pp. 25569-25575, 2009.
176. C. M. van Stijn, J. Kim, A. J. Lusis, G. D. Barish, and R. K. Tangirala, "Macrophage polarization phenotype regulates adiponectin receptor expression and adiponectin anti-inflammatory response," The FASEB Journal, vol. 29, no. 2, pp. 636-649, 2015.
177. H. A. Periyalil, P. G. Gibson, and L. G. Wood, "Immunometabolism in obese asthmatics: Are we there yet?" Nutrients, vol. 5, no. 9, pp. 3506-3530, 2013.
178. O. L. Klein, J. A. Krishnan, S. Glick, and L. J. Smith, "Systematic review of the association between lung function and Type 2 diabetes mellitus," DiabeticMedicine, vol. 27, no. 9, pp. 977-987, 2010.
179. B. G. J. Dekkers, D. Schaafsma, T. Tran, J. Zaagsma, and H. Meurs, "Insulin-induced laminin expression promotes a hypercontractile airway smooth muscle phenotype," American Journal of Respiratory Cell and Molecular Biology, vol. 41, no. 4, pp. 494-504, 2009.
180. G. T. McMahon and R. A. Arky, "Inhaled insulin for diabetes mellitus,"The New England Journal of Medicine, vol. 356, no. 5, pp. 497-502, 2007.
181. A. Agrawal, U. Mabalirajan, T. Ahmad, and B. Ghosh, "Emerging interface between metabolic syndrome and asthma," American Journal of Respiratory Cell and Molecular Biology, vol. 44, no. 3, pp. 270-275, 2011.
182. S. Singh, Y. S. Prakash, A. Linneberg, and A. Agrawal, "Insulin and the lung: connecting asthma and metabolic syndrome," Journal of Allergy, vol. 2013,Article ID 627384, 8 pages, 2013.
183. P. Dandona, A. Aljada, P. Mohanty et al., "Insulin inhibits intranuclear nuclear factor B and stimulates I B in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?" Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 7, pp. 3257-3265, 2001.
184. H. Ghanim, K. Green, S. Abuaysheh et al., "Suppressive effect of insulin on the gene expression and plasma concentrations of mediators of asthmatic inflammation," Journal of Diabetes Research, vol. 2015,Article ID 202406, 7 pages, 2015.
185. M. Cazzola, L. Calzetta, P. Rogliani et al., "High glucose enhances responsiveness of human airways smooth muscle via the Rho/ROCK pathway," American Journal of Respiratory Cell and Molecular Biology, vol. 47, no. 4, pp. 509-516, 2012.
186. W. W. Chance, C. Rhee, C. Yilmaz et al., "Diminished alveolar microvascular reserves in type 2 diabetes reflect systemic microangiopathy," Diabetes Care, vol. 31, no. 8, pp. 1596-1601, 2008.
187. H. O. Koskela, P. H. Salonen, and L. Niskanen, "Hyperglycaemia during exacerbations of asthma and chronic obstructive pulmonary disease," Clinical Respiratory Journal, vol. 7, no. 4, pp. 382-389, 2013.
188. E. Gulcan, I. Bulut, A. Toker, and A. Gulcan, "Evaluation of glucose tolerance status in patients with asthma bronchiale," Journal of Asthma, vol. 46, no. 2, pp. 207-209, 2009.
189. K. P. Dawson, A. C. Penna, and P. Manglick, "Acute asthma, salbutamol and hyperglycaemia," Acta Paediatrica, vol. 84, no. 3, pp. 305-307, 1995.
190. P. M. O'Byrne, S. Rennard, H. Gerstein et al., "Risk of new onset diabetesmellitus in patients with asthma or COPDtaking inhaled corticosteroids," Respiratory Medicine, vol. 106, no. 11, pp. 1487-1493, 2012.
191. A. G. Desai, A. Togias, C. Schechter, B. Fisher, A. Parow, and G. Skloot, "Peripheral airways dysfunction in obesity reflects increased bronchomotor tone," The Journal of Allergy and Clinical Immunology, vol. 135, no. 3, pp. 820-822, 2015.
192. A. Al-Alwan, J. H. T. Bates, D. G. Chapman et al., "The Nonallergic asthma of obesity: A matter of distal lung compliance," American Journal of Respiratory and Critical CareMedicine, vol. 189, no. 12, pp. 1494-1502, 2014.
193. J. H. T. Bates and A. E. Dixon, "Potential role of the airwaywall in the asthma of obesity," Journal of Applied Physiology, vol. 118, no. 1, pp. 36-41, 2015.
194. A. Agrawal and Y. S. Prakash, "Obesity, metabolic syndrome, and airway disease: A bioenergetic problem?" Immunology and Allergy Clinics of North America, vol. 34, no. 4, pp. 785-796, 2014.
195. A. Gardner, A. Johansson, R. Wibom et al., "Alterations ofmitochondrial function and correlations with personality traits in selected major depressive disorder patients," Journal of Affective Disorders, vol. 76, no. 1-3, pp. 55-68, 2003.
196. C. C. Chang, S. H. Jou, T. T. Lin, T. Lai, C. Liu, and Y. Bai, "Mitochondria DNA change and oxidative damage in clinically stable patients with major depressive disorder," PLoS ONE, vol. 10, no. 5, Article ID e0125855, 2015.
197. M. K. Montgomery and N. Turner, "Mitochondrial dysfunction and insulin resistance: An update," Endocrine Connections, vol. 4, no. 1, pp. R1-R15, 2014.
198. K. F. Petersen, D. Befroy, S. Dufour et al., "Mitochondrial dysfunction in the elderly: possible role in insulin resistance," Science, vol. 300, no. 5622, pp. 1140-1142, 2003.
199. U. Mabalirajan, A. K. Dinda, S. Kumar et al., "Mitochondrial structural changes and dysfunction are associated with experimental allergic asthma," The Journal of Immunology, vol. 181, no. 5, pp. 3540-3548, 2008.
200. L. Aguilera-Aguirre, A. Bacsi, A. Saavedra-Molina, A. Kurosky, S. Sur, and I. Boldogh, "Mitochondrial dysfunction increases allergic airway inflammation," The Journal of Immunology, vol. 183, no. 8, pp. 5379-5387, 2009.
201. E. K. Larkin, Y.-T. Gao, T. Gebretsadik et al., "New risk factors for adult-onset incident asthma. A nested case-control study of host antioxidant defense," American Journal of Respiratory and Critical Care Medicine, vol. 191, no. 1, pp. 45-53, 2015.
202. I. Palomo, A. Contreras, L. M. Alarcón et al., "Elevated concentration of asymmetric dimethylarginine (ADMA)in individuals withmetabolic syndrome," Nitric Oxide: Biology and Chemistry, vol. 24, no. 4, pp. 224-228, 2011.
203. J. A. Scott, M. L. North, M. Rafii et al., "Asymmetric dimethylarginine is increased in asthma," American Journal of Respiratory and Critical CareMedicine, vol. 184, no. 7,pp. 779-785, 2011.
204. K. Krzyzanowska, F. Mittermayer, H.-P. Kopp, M. Wolzt, and G. Schernthaner, "Weight loss reduces circulating asymmetrical dimethylarginine concentrations in morbidly obese women," The Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 12, pp. 6277-6281, 2004.
205. M. A. Mcevoy, P. Schofield, W. Smith et al., "Serum methylarginines and incident depression in a cohort of older adults," Journal of Affective Disorders, vol. 151, no. 2, pp. 493-499, 2013.
206. M. L. Selley, "Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression," Journal of Affective Disorders, vol. 80, no. 2-3, pp. 249-256, 2004.
207. F. Holguin, S. A. A. Comhair, S. L. Hazen et al., "An association between L-arginine/asymmetric dimethyl arginine balance, obesity, and the age of asthma onset phenotype," American Journal of Respiratory and Critical Care Medicine, vol. 187, no. 2, pp. 153-159, 2013.
208. L. Rochette, J. Lorin, M. Zeller et al., "Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?" Pharmacology&Therapeutics, vol. 140, no. 3, pp. 239-257, 2013.
209. S. M. Wells and A. Holian, "Asymmetric dimethylarginine induces oxidative and nitrosative stress in murine lung epithelial cells," American Journal of Respiratory Cell and Molecular Biology, vol. 36, no. 5, pp. 520-528, 2007.
210. T. Ahmad, U. Mabalirajan, B. Ghosh, and A. Agrawal, "Altered asymmetric dimethyl arginine metabolism in allergically inflamedmouse lungs,"American Journal of RespiratoryCell and Molecular Biology, vol. 42, no. 1, pp. 3-8, 2010.
211. P. Ilmarinen, E. Moilanen, J. S. Erjefält, and H. Kankaanranta, "The polyamine spermine promotes survival and activation of human eosinophils," The Journal of Allergy and Clinical Immunology, vol. 136, no. 2, pp. 482. e11-484. e11, 2015.
212. M. L. North, H. Grasemann, N. Khanna, M. D. Inman, G. M. Gauvreau, and J. A. Scott, "Increased ornithine-derived polyamines cause airway hyperresponsiveness in a mouse model of asthma," American Journal of Respiratory Cell and Molecular Biology, vol. 48, no. 6, pp. 694-702, 2013.
213. Z. Bagi, A. Feher, H. Dou, and Z. Broskova, "Selective up-regulation of arginase-1 in coronary arteries of diabetic patients," Frontiers in Immunology, vol. 4, article 293, 2013.
214. M. L. North, N. Khanna, P. A. Marsden, H. Grasemann, and J. A. Scott, "Functionally important role for arginase 1 in the airway hyperresponsiveness of asthma," American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 296, no. 6, pp. L911-L920, 2009.
215. R. Spanbroek, R. Gräbner, K. Lötzer et al., "Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis," Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 3, pp. 1238-1243, 2003.
216. F. Cipollone,A. Mezzetti,M. L. Fazia et al., "Association between 5-lipoxygenase expression and plaque instability in humans," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 8, pp. 1665-1670, 2005.
217. C. Pergola, G. Dodt, A. Rossi et al., "ERK-mediated regulation of leukotriene biosynthesis by and rogens: A molecular basis for gender differences in inflammation and asthma," Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 50, pp. 19881-19886, 2008.
218. M. Zaitsu, S.-I. Narita, K. C. Lambert et al., "Estradiol activates mast cells via a non-genomic estrogen receptor-alpha and calciuminflux.,"Molecular Immunology, vol. 44,no. 8, pp. 1977-1985, 2007.
219. H. Kankaanranta, P. Ilmarinen, T. Kankaanranta, and L. E. Tuomisto, "Seinäjoki Adult Asthma Study (SAAS): A protocol for a 12-year real-life follow-up study of new-onset asthma diagnosed at adult age and treated in primary and specialised care," NPJ Primary Care Respiratory Medicine, vol. 25, Article ID 15042, 2015.
220. P. Kirkham and I. Rahman, "Oxidative stress in asthma and COPD: Antioxidants as a therapeutic strategy," Pharmacology & Therapeutics, vol. 111, no. 2, pp. 476-494, 2006.